NCT01854359View on ClinicalTrials.gov

Idebenone for Primary Progressive Multiple Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 12, 2013

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Multiple SclerosisPrimary Progressive Multiple Sclerosis
Interventions
DRUG

Idebenone

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01854359 - Idebenone for Primary Progressive Multiple Sclerosis | Biotech Hunter | Biotech Hunter